Literature DB >> 16214904

Long-acting beta2-agonists in asthma: safety concerns.

Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16214904      PMCID： PMC1266322          DOI： 10.1503/cmaj.051224

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction.

Authors:  Allan Becker; Denis Bérubé; Zave Chad; Myrna Dolovich; Francine Ducharme; Tony D'Urzo; Pierre Ernst; Alexander Ferguson; Cathy Gillespie; Sandeep Kapur; Tom Kovesi; Brian Lyttle; Bruce Mazer; Mark Montgomery; Soren Pedersen; Paul Pianosi; John Joseph Reisman; Malcolm Sears; Estelle Simons; Sheldon Spier; Robert Thivierge; Wade Watson; Barry Zimmerman
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 2.  Salmeterol (Serevent) asthma trial halted early.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

3.  Serious asthma exacerbations in asthmatics treated with high-dose formoterol.

Authors:  Marianne Mann; Badrul Chowdhury; Eugene Sullivan; Richard Nicklas; Raymond Anthracite; Robert J Meyer
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

4.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Authors:  W Castle; R Fuller; J Hall; J Palmer
Journal:  BMJ       Date:  1993-04-17
  4 in total
  2 in total

1.  SMART therapy.

Authors:  Alan Bell; R Andrew McIvor
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

2.  In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2alpha overcomes the asthma-associated response.

Authors:  K A Whalen; H Legault; C Hang; A Hill; M Kasaian; D Donaldson; G W Bensch; G Bensch; J Baker; P S Reddy; N Wood; M K Ramarao; D K Ellis; C Csimma; C McKee; J D Clark; J Ryan; A J Dorner; M O'Toole
Journal:  Clin Exp Allergy       Date:  2008-07-28       Impact factor: 5.018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.